These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26536784)

  • 21. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
    Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
    J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic disturbances associated with systemic lupus erythematosus.
    Wu T; Xie C; Han J; Ye Y; Weiel J; Li Q; Blanco I; Ahn C; Olsen N; Putterman C; Saxena R; Mohan C
    PLoS One; 2012; 7(6):e37210. PubMed ID: 22723834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
    Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
    Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.
    Ferreira TAR; de Andrade HM; de Pádua PM; Carvalho MDG; Pires SDF; Oliveira IHR; Lima BSS; Fialho Júnior LC; Cicarini WB; Chapeourouge DA; Perales JH; Guimarães TMPD; Toledo VPCP
    Autoimmunity; 2017 Jun; 50(4):247-256. PubMed ID: 28675715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus.
    He J; Tang D; Liu D; Hong X; Ma C; Zheng F; Zeng Z; Chen Y; Du J; Kang L; Yin L; Lu Q; Dai Y
    Clin Immunol; 2023 Jun; 251():109330. PubMed ID: 37075949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography-mass spectrometry.
    Zhou J; Chen J; Hu C; Xie Z; Li H; Wei S; Wang D; Wen C; Xu G
    J Pharm Biomed Anal; 2016 Aug; 127():60-7. PubMed ID: 26879423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery.
    Kotłowska A; Sworczak K; Stepnowski P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):359-63. PubMed ID: 21247813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of plasma nucleotides in patients with rheumatoid arthritis.
    Kishikawa T; Maeda Y; Nii T; Arase N; Hirata J; Suzuki K; Yamamoto K; Masuda T; Ogawa K; Tsuji S; Matsushita M; Matsuoka H; Yoshimura M; Tsunoda S; Ohshima S; Narazaki M; Ogata A; Saeki Y; Inohara H; Kumanogoh A; Takeda K; Okada Y
    Int Immunol; 2021 Jan; 33(2):119-124. PubMed ID: 32866240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolome analysis for discovering biomarkers of gastroenterological cancer.
    Suzuki M; Nishiumi S; Matsubara A; Azuma T; Yoshida M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():59-69. PubMed ID: 24636738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
    Yoshida M; Nishiumi S; Azuma T
    Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
    Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
    Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.
    Bengtsson AA; Trygg J; Wuttge DM; Sturfelt G; Theander E; Donten M; Moritz T; Sennbro CJ; Torell F; Lood C; Surowiec I; Rännar S; Lundstedt T
    PLoS One; 2016; 11(7):e0159384. PubMed ID: 27441838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE.
    Lee SM; Lee EM; Park JK; Jeon HS; Oh S; Hong S; Jung YM; Kim BJ; Kim SM; Norwitz ER; Lee EB; Louangsenlath S; Park CW; Jun JK; Park JS; Lee DY
    Sci Rep; 2019 Oct; 9(1):15169. PubMed ID: 31645572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic disturbances in systemic lupus erythematosus evaluated with UPLC-MS/MS.
    Tang KT; Chien HJ; Chang YH; Liao TL; Chen DY; Lai CC
    Clin Exp Rheumatol; 2024 Jan; 42(1):15-23. PubMed ID: 34874826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
    Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
    Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
    Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
    J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk.
    Jury EC; Peng J; Van Vijfeijken A; Martin Gutierrez L; Woodridge L; Wincup C; Pineda-Torra I; Ciurtin C; Robinson GA
    Rheumatology (Oxford); 2024 Oct; 63(10):2741-2753. PubMed ID: 38048621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
    Wen T; Gao L; Wen Z; Wu C; Tan CS; Toh WZ; Ong CN
    Mol Biosyst; 2013 Sep; 9(9):2370-8. PubMed ID: 23857124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.